MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

ONCOLOGY LETTERS

Kiss, I; Mlcochova, J; Souckova, K; Fabian, P; Poprach, A; Halamkova, J; Svoboda, M; Vyzula, R; Slaby, O, 2017: MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX. ONCOLOGY LETTERS 14(1), p. 743 - 750, doi: 10.3892/ol.2017.6255

Research Groups:

CEITEC authors: